Quick Answer
FRACTYL HEALTH, INC. reported Diluted EPS of $1.86 per share (loss) for fiscal year 2025.
FRACTYL HEALTH, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.86 | -14.8% |
| 2024 | -$1.62 | +96.4% |
| 2023 | -$45.29 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.71 | -47.9% | -24.6% |
| June 30, 2025 | -$0.57 | -58.3% | -16.3% |
| March 31, 2025 | -$0.49 | -188.2% | -2.1% |
| September 30, 2024 | -$0.48 | +95.0% | -33.3% |
| June 30, 2024 | -$0.36 | +97.8% | -111.8% |
| March 31, 2024 | -$0.17 | +97.8% | +98.2% |
| September 30, 2023 | -$9.61 | — | +42.2% |
| June 30, 2023 | -$16.62 | — | -111.2% |
- FRACTYL HEALTH, INC. showed a decrease of -14.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2023–2025 period, FRACTYL HEALTH, INC.’s diluted eps has grown by 95.9% (from $45.29 per share (loss) to $1.86 per share (loss)).
- The most recent figure is from FRACTYL HEALTH, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: